Israel Englander’s 10x Genomics TXG Stock Holding History

Israel Englander’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-377,300	Closed	-$8.01M	–	6421
2026 Q1	$8.01M	Buy	+377,300	New	+$7.54M	﹤0.01%	2401
2025 Q3	–	Sell	-60,000	Closed	-$695K	–	6485
2025 Q2	$695K	Buy	+60,000	New	+$547K	﹤0.01%	4672
2025 Q1	–	Sell	-15,000	Closed	-$215K	–	6408
2024 Q4	$215K	Sell	15,000 -55,000	-79%	-$868K	﹤0.01%	5272
2024 Q3	$1.58M	Buy	+70,000	New	+$1.45M	﹤0.01%	3916
2022 Q3	–	Sell	-10,000	Closed	-$453K	–	7509
2022 Q2	$453K	Buy	+10,000	New	+$519K	﹤0.01%	5042
2022 Q1	–	Sell	-2,000	Closed	-$298K	–	7504
2021 Q4	$298K	Buy	+2,000	New	+$306K	﹤0.01%	5552

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Israel Englander's TXG Position: Q2 2026 in Review

Israel Englander reduced its 10x Genomics (TXG) stake by 94% in Q2 2026, selling an estimated $51.1M and leaving 116,833 shares worth $4.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3095.

Israel Englander first reported a position in TXG in Q3 2019 and has held it in 25 quarters since. The position peaked at $63.6M in Q3 2025. 389 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Israel Englander held 116,833 shares of 10x Genomics worth $4.48M as of Q2 2026.
Israel Englander sold 1,951,581 10x Genomics shares in Q2 2026, an estimated $51.1M.
10x Genomics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3095 holding.
Israel Englander first reported a position in 10x Genomics in Q3 2019 and has held it in 25 quarters since.
Israel Englander's 10x Genomics position peaked at $63.6M in Q3 2025.
389 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.